Cargando...
Durable complete response to nivolumab in a patient with HIV and metastatic non-small cell lung cancer
Programmed death 1 (PD-1) inhibitors have been shown to increase overall survival in non-small cell lung cancer (NSCLC) patients. HIV patients have increased expression of PD-1 on their T-cell surfaces. We describe a patient with well-controlled HIV and NSCLC who underwent treatment with nivolumab a...
Gardado en:
| Publicado en: | J Thorac Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AME Publishing Company
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5506156/ https://ncbi.nlm.nih.gov/pubmed/28740692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.05.32 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|